2025 annual financial data
Skye Bioscience 2025 Operating margin
Skye Bioscience 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -58,163,565 USD and net income was -55,924,814 USD.
Operating cash flow was -43,062,529 USD.
Get free Skye Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -58,163,565 USD
- Net income
- -55,924,814 USD
- Operating cash flow
- -43,062,529 USD